BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai FY, Yao XM, Jing M, Kong L, Liu JJ, Fu M, Liu XZ, Zhang L, He SY, Li XT, Ju RJ. Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition. J Liposome Res 2021;31:113-29. [PMID: 32200703 DOI: 10.1080/08982104.2020.1745831] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Allahyari S, Zahednezhad F, Khatami M, Hashemzadeh N, Zakeri-milani P, Trotta F. Cyclodextrin nanosponges as potential anticancer drug delivery systems to be introduced into the market, compared with liposomes. Journal of Drug Delivery Science and Technology 2022;67:102931. [DOI: 10.1016/j.jddst.2021.102931] [Reference Citation Analysis]
2 Yan C, Gao L, Qiu X, Deng C. Schisandrin B synergizes docetaxel-induced restriction of growth and invasion of cervical cancer cells in vitro and in vivo. Ann Transl Med 2020;8:1157. [PMID: 33241006 DOI: 10.21037/atm-20-6109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]